Correlation Between Fortress Biotech and Gain Therapeutics

Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fortress Biotech Pref and Gain Therapeutics, you can compare the effects of market volatilities on Fortress Biotech and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Gain Therapeutics.

Diversification Opportunities for Fortress Biotech and Gain Therapeutics

-0.08

Correlation Coefficient

Fortress Biotech  Gain Therapeutics

Good diversification

The 3 months correlation between Fortress and Gain is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech Pref and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech Pref are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Gain Therapeutics go up and down completely randomly.

Pair Corralation between Fortress Biotech and Gain Therapeutics

Assuming the 90 days horizon Fortress Biotech Pref is expected to generate 0.74 times more return on investment than Gain Therapeutics. However, Fortress Biotech Pref is 1.35 times less risky than Gain Therapeutics. It trades about 0.35 of its potential returns per unit of risk. Gain Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  510.00  in Fortress Biotech Pref on September 16, 2024 and sell it today you would earn a total of  188.00  from holding Fortress Biotech Pref or generate 36.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fortress Biotech Pref  vs.  Gain Therapeutics

Fortress Biotech Pref

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech Pref are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Fortress Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Gain Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Gain Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Gain Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Fortress Biotech and Gain Therapeutics

The main advantage of trading using opposite Fortress Biotech and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.

The idea behind Fortress Biotech Pref and Gain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.